Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alphamab Oncology ( (HK:9966) ) has provided an update.
Alphamab Oncology has established a Nomination Committee to enhance its corporate governance structure. The committee will be responsible for reviewing the board’s composition, identifying qualified candidates for directorships, and ensuring board diversity. This move is expected to strengthen the company’s strategic direction and improve stakeholder confidence.
More about Alphamab Oncology
Average Trading Volume: 3,985,865
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.94B
For detailed information about 9966 stock, go to TipRanks’ Stock Analysis page.